Establishing the cascade of care for patients with tuberculous meningitis
Authors:
- Darma ImranDIDarma Imran
- Philip C. HillPHPhilip C. Hill
- Jacob McKnightJMJacob McKnight
- Reinout van CrevelRCReinout van Crevel
- Tuberculous Meningitis International Research ConsortiumTCTuberculous Meningitis International Research Consortium
Open Access
- 13 November 2019
- journal article
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 4, 177
Abstract
Meningitis is a relatively rare form of tuberculosis, but it carries a high mortality rate, reaching 50% in some settings, with higher rates among patients with HIV co-infection and those with drug-resistant disease. Most studies of tuberculosis meningitis (TBM) tend to focus on better diagnosis, drug treatment and supportive care for patients in hospital. However, there is significant variability in mortality between settings, which may be due to specific variation in the availability and quality of health care services, both prior to, during, and after hospitalization. Such variations have not been studied thoroughly, and we therefore present a theoretical framework that may help to identify where efforts should be focused in providing optimal services for TBM patients. As a first step, we propose an adjusted cascade of care for TBM and patient pathway studies that might help identify factors that account for losses and delays across the cascade. Many of the possible gaps in the TBM cascade are related to health systems factors; we have selected nine domains and provide relevant examples of systems factors for TBM for each of these domains that could be the basis for a health needs assessment to address such gaps. Finally, we suggest some immediate action that could be taken to help make improvements in services. Our theoretical framework will hopefully lead to more health system research and improved care for patients suffering from this most dangerous form of tuberculosis.Keywords
Funding Information
- Medical Research Council (MR/S004963/1)
- National Institutes of Health (R01AI145781)
This publication has 28 references indexed in Scilit:
- Improving the cascade of global tuberculosis care: moving from the “what” to the “how” of quality improvementThe Lancet Infectious Diseases, 2019
- The neurocritical care of tuberculous meningitisThe Lancet Neurology, 2019
- Building a tuberculosis-free world: The Lancet Commission on tuberculosisThe Lancet, 2019
- Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain, GeneXpert, and culture of cerebrospinal fluidJournal of Infection, 2018
- Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in IndonesiaDiagnostic Microbiology and Infectious Disease, 2018
- Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort studyThe Lancet Infectious Diseases, 2018
- Corticosteroids for managing tuberculous meningitisCochrane Database of Systematic Reviews, 2016
- Organizational issues in the implementation and adoption of health information technology innovations: An interpretative reviewInternational Journal of Medical Informatics, 2013
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trialThe Lancet Infectious Diseases, 2013
- The neurosurgical and acute care management of tuberculous meningitis: Evidence and current practiceTuberculosis, 2010